Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F13%3A43907902" target="_blank" >RIV/00216208:11120/13:43907902 - isvavai.cz</a>
Alternative codes found
RIV/00064173:_____/13:#0000365
Result on the web
<a href="http://dx.doi.org/10.1016/S0140-6736(13)61451-8" target="_blank" >http://dx.doi.org/10.1016/S0140-6736(13)61451-8</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S0140-6736(13)61451-8" target="_blank" >10.1016/S0140-6736(13)61451-8</a>
Alternative languages
Result language
angličtina
Original language name
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial
Original language description
Treatment with prasugrel and aspirin improves outcomes compared with clopidogrel and aspirin for patients with acute coronary syndrome who have had angiography and percutaneous coronary intervention; however, no clear benefit has been shown for patientsmanaged first with drugs only. We assessed outcomes from the TRILOGY ACS trial based on whether or not patients had coronary angiography before treatment was chosen. TRILOGY ACS was a randomised controlled trial, done at more than 800 sites worldwide. Patients with non-ST-elevation acute coronary syndrome who were selected for management with revascularisation were randomly assigned to clopidogrel or prasugrel. The primary endpoint was cardiovascular death, myocardial infarction, or stroke at 30 months.In the present analysis we assessed differences in the primary endpoint by angiography status and whether the effects of treatment on the primary endpoint differed between patients who had angiography before enrolment and those who had n
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Lancet
ISSN
0140-6736
e-ISSN
—
Volume of the periodical
382
Issue of the periodical within the volume
9892
Country of publishing house
GB - UNITED KINGDOM
Number of pages
9
Pages from-to
605-613
UT code for WoS article
000323422800024
EID of the result in the Scopus database
—